stockrow
Friday 6 November 2026
Export DH’s income statement to Excel — free account
Definitive Healthcare Corp.
DH Healthcare Health Information Services
Definitive Healthcare Corp.’s revenue for fiscal 2025 (year ended December 2025) was $241.5 million, down 4.24% from fiscal 2024.
- Revenue
- −8.99%
- EPS
- +71.4%
- Free cash flow
- −32.6%
- Total debt
- −5.03%
Quarter to September 2026, against a year earlier
1.16
0.03
+2.65%
Follow DH
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.43 | 0.38 | 0.54 | 1.27 | |
P/FCF ratio |
4.02 | 3.07 | 4.76 | 8.26 | |
P/Operating CF |
8.51 | 7.67 | 11.13 | 112.53 | |
P/B ratio |
0.52 | 0.47 | 0.68 | 0.81 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.29 | 0.28 | 0.48 | 1.20 | |
EV/EBITDA |
1.48 | 1.46 | 2.38 | 6.55 | |
EV/Operating CF |
1.77 | 1.57 | 2.89 | 5.39 | |
EV/FCF |
2.72 | 2.27 | 4.19 | 7.83 | |
Quick Ratio |
1.77 | 1.66 | 1.55 | 1.49 | |
Current Ratio |
1.96 | 1.86 | 1.75 | 1.64 | |
Net Debt/EBITDA |
0.00 | (2.10) | (1.17) | (1.48) | |
Debt/Assets |
32.44% | 32.33% | 31.62% | 22.41% | |
Debt/Equity |
0.84 | 0.86 | 0.85 | 0.43 | |
Asset Turnover |
0.37 | 0.37 | 0.36 | 0.26 | |
Operating CF/Net income |
(2.93) | (2.11) | (0.08) | (0.29) | |
Capex/Depreciation |
0.00 | (0.17) | (0.01) | (0.12) | |
Interest Coverage |
(1.87) | (2.57) | (76.57) | (9.29) | |
Research and Development Expense of Revenue |
12.20% | 12.24% | 11.62% | 16.18% | |
Selling, General and Administrative Expense of Revenue |
57.66% | 54.29% | 56.61% | 56.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.45 | 0.46 | 0.60 | |
Share Based Compensation of Revenue |
10.11% | 9.52% | 9.33% | 13.26% | |
Graham Net Nets |
(0.58) | (0.78) | (0.61) | (0.32) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(164.84%) | (192.77%) | (131.71%) | (43.55%) | |
Free Cash Flow Yield |
24.90% | 32.52% | 21.02% | 12.11% | |
Revenue per Share |
0.51 | 0.52 | 0.53 | 0.58 | |
Operating CF per Share |
0.11 | 0.11 | 0.11 | 0.03 | |
Capex per Share |
(0.02) | (0.03) | (0.03) | (0.04) | |
Free Cash Flow per Share |
0.08 | 0.08 | 0.08 | (0.02) | |
Cash per Share |
1.78 | 1.74 | 1.70 | 1.70 | |
Shareholders Equity per Share |
1.77 | 1.78 | 1.82 | 3.55 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.77 | 1.78 | 1.82 | 3.55 | |
Free Cash Flow |
9.04 | 8.51 | 8.36 | (1.72) | |
Working Capital |
119.57 | 111.03 | 105.35 | 100.82 | |
Capital Expenditures |
(2.39) | (2.94) | (3.20) | (4.44) | |
Net Current Asset Value |
(56.46) | (68.87) | (78.28) | (98.89) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.05 | 0.06 | 0.07 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
31.94 | 34.24 | 40.93 | 52.61 | |
Average Payables |
7.20 | 6.21 | 7.12 | 7.18 | |
Average Assets |
622.09 | 633.49 | 661.70 | 912.44 | |
Average Common Equity |
289.07 | 299.55 | 313.30 | 493.09 |
Columns are period end dates · fundamentals updated 5 Nov 2026